Zhou Zhang

Zhou Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2018 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
PDF file
HZHong-Feng Zhang
Hong-Feng Zhang
YWYan-Li Wang
Yan-Li Wang
CGCheng Gao
Cheng Gao
YGYan-Ting Gu
Yan-Ting Gu
JHJian Huang
Jian Huang
ZZZhou Zhang
Zhou Zhang
Salvianolic acid A (SAA) is a minor phenolic carboxylic acid extracted from Salviae miltiorrhizae Bunge (Danshen). SAA exhibits a variety of pharmacological activities, such as antioxidative, anti-thrombotic, neuroprotective, and anti-fibrotic effects, as well as protection from myocardial ischemia and prevention of diabetes and other diseases. Furthermore, SAA has shown renal-protective effects in doxorubicin-induced nephropathy. However, there has been limited research regarding the effects of SAA and underlying mechanisms in chronic kidney disease (CKD). Here, we examined the effects and molecular mechanisms of SAA in an established animal model of 5/6 nephrectomized (5/6Nx) rats. The rats were injected with SAA (2.5, 5, and 10 mg/kg per day, intraperitoneally (ip)) for 28 days. SAA dose-dependently lowered the levels of urine protein, blood urea nitrogen, serum creatinine, plasma total cholesterol, and plasma triglycerides in 5/6Nx rats. Histological examination revealed that SAA dose-dependently attenuated renal pathological lesions, evidenced by reduced renal tubulointerstitial fibrosis by decreasing the expression levels of tumor growth factor-β1 and α-smooth muscle actin in 5/6Nx rats. Moreover, SAA dose-dependently inhibited the activation of nuclear factor-κB (NF-κB) and p38 mitogen-activated protein kinase (MAPK) signaling pathways, subsequently attenuating the secretion of tumor necrosis factor-α and interleukin-1β and inhibiting the expression of monocyte chemotactic protein-1, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in kidneys of 5/6Nx rats. The above results were consistent with those obtained in lipopolysaccharide-induced HK-2 cells in vitro (a recognized in vitro inflammatory model). In conclusion, our results demonstrated that SAA effectively attenuates kidney injury in 5/6Nx rats. The therapeutic effects of SAA on kidney injury can be attributed to its anti-inflammatory activities through inhibition of the activation of the NF-κB and p38 MAPK signaling pathways.

18 March 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HZHong-Feng Zhang
Hong-Feng Zhang
JWJia-Hong Wang
Jia-Hong Wang
YWYan-Li Wang
Yan-Li Wang
CGCheng Gao
Cheng Gao
YGYan-Ting Gu
Yan-Ting Gu
ZZZhou Zhang
Zhou Zhang
Salvianolic acid A (SAA) is a bioactive polyphenol extracted from Salviae miltiorrhizae Bunge, which possesses a variety of pharmacological activities. In our previous study, we have demonstrated that SAA effectively attenuates kidney injury and inflammation in an established animal model of 5/6 nephrectomized (5/6Nx) rats. However, there has been limited research regarding the antioxidative effects of SAA on chronic kidney disease (CKD). Here, we examined the antioxidative effects and underlying mechanisms of SAA in 5/6Nx rats. The rats were injected with SAA (2.5, 5, and 10 mg·kg-1·d-1, ip) for 28 days. Biochemical, flow cytometry, and Western blot analyses showed that SAA significantly increased the activities of total superoxide dismutase (T-SOD), glutathione peroxidase (GPx), and catalase (CAT) and lowered the levels of malondialdehyde (MDA), reactive oxygen species (ROS), and NADPH oxidase 4 (NOX-4) in a dose-dependent manner in 5/6Nx rats and in H2O2-induced HK-2 cells in vitro. Moreover, SAA enhanced the activation of the protein kinase B/glycogen synthase kinase-3β/nuclear factor-erythroid-2-related factor 2 (Akt/GSK-3β/Nrf2) signaling pathway in a dose-dependent manner and subsequently increased the expression of heme oxygenase-1 (HO-1) in the kidney of 5/6Nx rats, which were consistent with those obtained in H2O2-induced HK-2 cells in vitro shown by Western blot analysis. Furthermore, SAA significantly increased the expression of intranuclear Nrf2 and HO-1 proteins compared to HK-2 cells stimulated by LPS on the one hand, which can be enhanced by QNZ to some extent; on the other hand, SAA significantly lowered the expression of p-NF-κB p65 and ICAM-1 proteins compared to HK-2 cells stimulated by H2O2, which can be abrogated by ML385 to some extent. In conclusion, our results demonstrated that SAA effectively protects the kidney against oxidative stress in 5/6Nx rats. One of the pivotal mechanisms for the protective effects of SAA on kidney injury was mainly related with its antioxidative roles by activating the Akt/GSK-3β/Nrf2 signaling pathway and inhibiting the NF-κB signaling pathway.

19 July 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YGYanting Gu
Yanting Gu
RCRuiping Cai
Ruiping Cai
CZCai Zhang
Cai Zhang
YXYixue Xue
Yixue Xue
YPYali Pan
Yali Pan
ZZZhou Zhang
Zhou Zhang
Blood–brain tumor barrier (BTB) impedes the transportation of antitumor therapeutic drugs into brain tumors. Its mechanism is still unknown, but learning how to improve the BTB permeability is critical for drug intervention. Recently, microRNAs (miRNAs) have appeared as regulation factors of numerous biologic processes and therapeutic targets of diverse diseases. In this study, we have identified that miR‐132‐3p is an essential miRNA by increasing the transcellular transport through the BTB. We found that miR‐132‐3p expression was significantly up‐regulated in glioma endothelial cells (GECs). Furthermore we showed that miR132‐3p + greatly induced the endocytosis of cholera toxin subunit B and FITC–bovine serum albumin and up‐regulated the expression of p‐PKB, p‐Src and Tyr14 phosphorylation of caveolin‐1 (p‐Cav‐1), while phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression was markedly down‐regulated in GECs. Our results identify PTEN as a direct and functional downstream target of miR‐132‐3p, which is involved in the regulation of p‐PKB, p‐Src, and p‐Cav‐1. The inhibitors for PI3K and Src significantly reversed the increase of p‐Cav‐1 induced by miR‐132‐3p. Moreover, overexpression of PTEN greatly reduced the endocytosis of cholera toxin subunit B and the up‐regulation of p‐Cav‐1 induced by agomiR132‐3p, suggesting that miR132‐3p + increases the endothelial permeability by inhibition of PTEN expression. In addition, miR132‐3p + significantly increased the delivery of doxorubicin across the BTB in vitro and contributed to the accumulation of doxorubicin within the brain tumor tissue. Our results show that miR‐132‐3p contributes to the increased permeability of BTB by targeting PTEN/PI3K/PKB/Src/Cav‐1, thereby revealing a novel drug target for the treatment of brain gliomas.—Gu, Y., Cai, R., Zhang, C., Xue, Y., Pan, Y., Wang, J., Zhang, Z. miR‐132‐3p boosts caveolae‐mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav‐1 signaling pathway. FASEB J. 33, 441–454 (2019). www.fasebj.org

31 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SGSirui Guo
Sirui Guo
JWJiahong Wang
Jiahong Wang
YWYunjia Wang
Yunjia Wang
YZYing Zhang
Ying Zhang
KBKaishun Bi
Kaishun Bi
QLQing Li
Qing Li
Kai-Xin-San (KXS), a classical Chinese traditional prescription, was widely applied in the treatment of Alzheimer’s disease (AD), while its functional mechanisms still remain unclear. By using systems biology approaches at animal, cellular, and molecular levels, the improvement of KXS on cognitive impairment was achieved by inhibiting abnormal acetylcholinesterase. The function on the nerve skeleton was performed by regulating the Tau phosphorylation pathway. Its antioxidant, anti-inflammatory, and antiapoptotic effects by modulating the aberrant upregulation of ROS, proinflammatory factors, and apoptosis-related proteins in the brain were studied to reveal the synergistic therapeutic efficacy of KXS. Then, formula dismantling in vitro indicated that ginseng was the principal herb, whereas three other herbs served adjuvant roles to achieve the best effect. After that, the in vivo analysis of components into plasma and brain of AD rats showed that 8 of 23 components in blood and 4 of 10 components in brain were from ginseng, respectively, further verifying the principal status of ginseng and the synergistic effects of the formula. Thus, the anti-AD effects of KXS were achieved by multitargets and multichannels. The systems biology approaches presented here provide a novel way in traditional herbal medicine research.

1 July 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
SGSirui Guo
Sirui Guo
JWJiahong Wang
Jiahong Wang
HXHuarong Xu
Huarong Xu
WRWeiwei Rong
Weiwei Rong
CGCheng Gao
Cheng Gao
QLQing Li
Qing Li
Alzheimer’s disease (AD) is a widespread neurodegenerative disease caused by complicated disease-causing factors. Unsatisfactorily, curative effects of approved anti-AD drugs were not good enough due to their actions on single-target, which led to desperate requirements for more effective drug therapies involved in multiple pathomechanisms of AD. The anti-AD effect with multiple action targets of Kai-Xin-San (KXS), a classic prescription initially recorded in Bei Ji Qian Jin Yao Fang and applied in the treatment of dementia for thousands of years, was deciphered with modern biological methods in our study. Aβ25-35 and D-gal-induced AD rats and Aβ25-35-induced PC12 cells were applied to establish AD models. KXS could significantly improve cognition impairment by decreasing neurotransmitter loss and enhancing the expression of PI3K/Akt. For the first time, KXS was confirmed to improve the expression of PI3K/Akt by neurotransmitter 5-HT. Thereinto, PI3K/Akt could further inhibit Tau hyperphosphorylation as well as the apoptosis induced by oxidative stress and neuroinflammation. Moreover, all above-mentioned effects were verified and blocked by PI3K inhibitor, LY294002, in Aβ25-35-induced PC12 cells, suggesting the precise regulative role of KXS in the PI3K/Akt pathway. The utilization and mechanism elaboration of KXS have been proposed and dissected in the combination of animal, molecular, and protein strategies. Our results demonstrated that KXS could ameliorate AD by regulating neurotransmitter and PI3K/Akt signal pathway as an effective multitarget treatment so that the potential value of this classic prescription could be explored from a novel perspective.

1 May 2020 in Neuropharmacology
Verified
Journal Article
Closed access
CZCai Zhang
Cai Zhang
YPYali Pan
Yali Pan
RCRuiping Cai
Ruiping Cai
SGSirui Guo
Sirui Guo
XZXiaoyi Zhang
Xiaoyi Zhang
ZZZhou Zhang
Zhou Zhang